06/03/2022
THCV, another cannabinoid tested at BlueLeaf Laboratory, may provide a therapeutic alternative for individuals suffering from type 2 diabetes or other metabolic diseases, according to researchers.
**p **ptesting
Source: Abioye, Amos. “Δ9-Tetrahydrocannabivarin (THCV): a Commentary on Potential Therapeutic Benefit for the Management of Obesity and Diabetes.” Journal of Cannabis Research, vol. 2, 31 Jan. 2020, pp. 2–14.